Lung cancer immunotherapy.

Luis E. Raez, Steven Fein, Eckhard R. Podack

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Recent insights into anti-tumor immunotherapy have led to a wave of clinical trials involving immunotherapy for lung cancer. Vaccines have evolved from nonspecific immune stimulants, like Bacillus Calmette-Guerin (BCG), to much more specific and potent strategies, some of which generate active immune responses against tumor-associated antigens. Understanding the mechanisms of anti-tumor immunity and identifying target antigens will likely improve these therapeutic strategies and provide them with a niche in the future of lung cancer therapy.

Original languageEnglish
Pages (from-to)221-228
Number of pages8
JournalClinical medicine & research
Volume3
Issue number4
StatePublished - Nov 1 2005
Externally publishedYes

Fingerprint

Immunotherapy
Lung Neoplasms
Active Immunity
Neoplasm Antigens
Mycobacterium bovis
Immunity
Neoplasms
Vaccines
Clinical Trials
Antigens
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)
  • Community and Home Care

Cite this

Raez, L. E., Fein, S., & Podack, E. R. (2005). Lung cancer immunotherapy. Clinical medicine & research, 3(4), 221-228.

Lung cancer immunotherapy. / Raez, Luis E.; Fein, Steven; Podack, Eckhard R.

In: Clinical medicine & research, Vol. 3, No. 4, 01.11.2005, p. 221-228.

Research output: Contribution to journalArticle

Raez, LE, Fein, S & Podack, ER 2005, 'Lung cancer immunotherapy.', Clinical medicine & research, vol. 3, no. 4, pp. 221-228.
Raez LE, Fein S, Podack ER. Lung cancer immunotherapy. Clinical medicine & research. 2005 Nov 1;3(4):221-228.
Raez, Luis E. ; Fein, Steven ; Podack, Eckhard R. / Lung cancer immunotherapy. In: Clinical medicine & research. 2005 ; Vol. 3, No. 4. pp. 221-228.
@article{292f3b056fd3452f95ad7fdf896ab3bc,
title = "Lung cancer immunotherapy.",
abstract = "Recent insights into anti-tumor immunotherapy have led to a wave of clinical trials involving immunotherapy for lung cancer. Vaccines have evolved from nonspecific immune stimulants, like Bacillus Calmette-Guerin (BCG), to much more specific and potent strategies, some of which generate active immune responses against tumor-associated antigens. Understanding the mechanisms of anti-tumor immunity and identifying target antigens will likely improve these therapeutic strategies and provide them with a niche in the future of lung cancer therapy.",
author = "Raez, {Luis E.} and Steven Fein and Podack, {Eckhard R.}",
year = "2005",
month = "11",
day = "1",
language = "English",
volume = "3",
pages = "221--228",
journal = "Clinical Medicine and Research",
issn = "1539-4182",
publisher = "Marshfield Clinic",
number = "4",

}

TY - JOUR

T1 - Lung cancer immunotherapy.

AU - Raez, Luis E.

AU - Fein, Steven

AU - Podack, Eckhard R.

PY - 2005/11/1

Y1 - 2005/11/1

N2 - Recent insights into anti-tumor immunotherapy have led to a wave of clinical trials involving immunotherapy for lung cancer. Vaccines have evolved from nonspecific immune stimulants, like Bacillus Calmette-Guerin (BCG), to much more specific and potent strategies, some of which generate active immune responses against tumor-associated antigens. Understanding the mechanisms of anti-tumor immunity and identifying target antigens will likely improve these therapeutic strategies and provide them with a niche in the future of lung cancer therapy.

AB - Recent insights into anti-tumor immunotherapy have led to a wave of clinical trials involving immunotherapy for lung cancer. Vaccines have evolved from nonspecific immune stimulants, like Bacillus Calmette-Guerin (BCG), to much more specific and potent strategies, some of which generate active immune responses against tumor-associated antigens. Understanding the mechanisms of anti-tumor immunity and identifying target antigens will likely improve these therapeutic strategies and provide them with a niche in the future of lung cancer therapy.

UR - http://www.scopus.com/inward/record.url?scp=34548058341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548058341&partnerID=8YFLogxK

M3 - Article

C2 - 16303887

AN - SCOPUS:34548058341

VL - 3

SP - 221

EP - 228

JO - Clinical Medicine and Research

JF - Clinical Medicine and Research

SN - 1539-4182

IS - 4

ER -